More importantly, a prognostic significance of AR and let-7a expression and their correlation was highlighted in invasive BC patients: high levels of AR and let-7a were correlated with and a small fraction of CD44+/CD24-/low tumor-initiating cells expressing a stemness phenotype and patients with these features showed a better outcome (54). This evidence concerns the gene CD44 and breast cancer.